Prescription Pattern of Tofacitinib for Alopecia Areata Among Dermatologists in Saudi Arabia: A Cross-Sectional Study

June 2023 in “ Cureus ”

Abdulaziz S Alsuhibani, Raghad Alharthi, Saba AlSuhaymi, Muhannad A Alnahdi, Mohammad Almohideb

Tofacitinib Alopecia Areata AA dermatologists effectiveness side effects

TLDR Some dermatologists in Saudi Arabia prescribe Tofacitinib for hair loss, but many don't due to its unavailability and safety concerns.

A cross-sectional study conducted in Saudi Arabia surveyed 546 dermatologists about their use of Tofacitinib, a drug used to treat Alopecia Areata (AA). It found that 23.2% (127) of the dermatologists prescribe Tofacitinib for AA, and 72.4% (92) of these believe it to be effective. However, 47.7% (200) of the dermatologists who do not prescribe Tofacitinib cited its unavailability as the main reason. The study also found a significant association between prescribing Tofacitinib and the dermatologist's gender, nationality, and position title, but not their years of experience. Despite previous studies showing Tofacitinib's effectiveness, the majority of dermatologists did not agree that Tofacitinib was safe, indicating a need for further research on the drug's effectiveness and side effects.

View this study on assets.cureus.com →

Discuss this study in the Community →

Research cited in this study

4 / 4 results

research Case Report of Novel Combination of Anthralin and Calcipotriene Leading to Trichologic Response in Alopecia Areata

6 citations, March 2019 in “JAAD case reports”

A new mix of anthralin and calcipotriene might help treat severe hair loss.

research JAK Inhibitors and Alopecia Areata

56 citations, January 2019 in “Lancet”

JAK inhibitors help regrow hair in alopecia areata patients, improving their quality of life.

research Tofacitinib for the Treatment of Severe Alopecia Areata and Variants: A Study of 90 Patients

238 citations, November 2016 in “Journal of The American Academy of Dermatology”

Tofacitinib is effective and safe for severe hair loss, but full regrowth is less likely after 10 years of hair loss.

research Oral Ruxolitinib Induces Hair Regrowth in Patients with Moderate-to-Severe Alopecia Areata

196 citations, September 2016 in “JCI insight”

Ruxolitinib effectively regrows hair in most patients with severe hair loss.

Related Research

2 / 2 results

research Resistant Alopecia Areata Treated with Tofacitinib

1 citations, September 2022 in “International Journal of Trichology”

Tofacitinib can be effective in treating hair loss caused by alopecia areata.

research Successful Treatment of Severe Alopecia Areata With Oral or Topical Tofacitinib

4 citations, July 2018 in “PubMed”

Oral and topical tofacitinib can help regrow hair in people with severe alopecia areata.

Prescription Pattern of Tofacitinib for Alopecia Areata Among Dermatologists in Saudi Arabia: A Cross-Sectional Study

Research cited in this study

research Case Report of Novel Combination of Anthralin and Calcipotriene Leading to Trichologic Response in Alopecia Areata

research JAK Inhibitors and Alopecia Areata

research Tofacitinib for the Treatment of Severe Alopecia Areata and Variants: A Study of 90 Patients

research Oral Ruxolitinib Induces Hair Regrowth in Patients with Moderate-to-Severe Alopecia Areata

Related Community Posts Join

community Female, 27 years old, shedding/ balding despite being on what is considered to be a effective treatment plan for AGA. Considering Dut (oral) . Please help.

community 22F. Should I even bother getting a biopsy? Is there any point?

community What else is good. Besides the big 3.

community The shedding caused by Minoxidil is one of the worst things. 2 months apart each picture

community No hair, don't care! [24/F] :)

community Finasteride and Oral Minoxidil in Turkey - what I’ve found out

Related Research

research Resistant Alopecia Areata Treated with Tofacitinib

research Successful Treatment of Severe Alopecia Areata With Oral or Topical Tofacitinib